Cargando…
Early body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancer
BACKGROUND AND PURPOSE: Radiation-esophagitis and weight loss are frequently observed toxicities in patients treated with concurrent chemo-radiotherapy (CT-RT) for non-small cell lung cancer (NSCLC) and might be related. The purpose was to investigate whether weight loss already starts early after i...
Autores principales: | Op den Kamp, Céline M. H., De Ruysscher, Dirk K. M., van den Heuvel, Marieke, Elferink, Meike, Houben, Ruud M. A., Oberije, Cary J. G., Bootsma, Gerben P., Geraedts, Wiel H., Pitz, Cordula C. M., Langen, Ramon C., Wouters, Emiel F. M., Schols, Annemie M. W. J., Dingemans, Anne-Marie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053563/ https://www.ncbi.nlm.nih.gov/pubmed/24452446 http://dx.doi.org/10.1007/s13539-013-0127-5 |
Ejemplares similares
-
Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study
por: Degens, Juliette, et al.
Publicado: (2020) -
Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia
por: Op den Kamp, Celine M, et al.
Publicado: (2015) -
A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients
por: Oberije, Cary, et al.
Publicado: (2015) -
Identification of microRNAs in skeletal muscle associated with lung cancer cachexia
por: van de Worp, Wouter R.P.H., et al.
Publicado: (2019) -
Investigation of the added value of CT-based radiomics in predicting
the development of brain metastases in patients with radically treated stage III
NSCLC
por: Keek, Simon A., et al.
Publicado: (2022)